← Open Payments lookup

JACOB GORDON: Open Payments

NPI 1417568049 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$708 in 27 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $708

Food & beverage: $708
CompanyPaymentsAmount
United Therapeutics Corporation7$256
Bayer Healthcare Pharmaceuticals Inc.4$101
Boehringer Ingelheim Pharmaceuticals, Inc.5$97
Actelion Pharmaceuticals US, Inc.3$76
Melinta Therapeutics, LLC2$33
Astellas Pharma US Inc1$32
Invivyd Inc2$31
Takeda Pharmaceuticals U.S.A., Inc.1$30
ABBVIE INC.1$26
Insmed, Inc.1$25

Products named: Adempas, Orenitram, JASCAYD, UPTRAVI, OFEV, Tyvaso, Rezzayo, Cresemba.

Industry payments across DC — which companies pay providers there.